Amazon Bio Discovery developed three AI approaches to accelerate antibody drug design: MochiBind (sequence-based affinity ranking), CA-MAP (developability prediction with batch effect correction), and an agent-guided design system with 46 lab-validated hits against a novel cancer target.
amazon.scienceAdvancing AI for biology: Teaching models to design and characterize antibodiesThree new papers from Amazon Bio Discovery address bottlenecks in AI-driven antibody engineering, from benchmarking binding predictors to experimentally validating de novo design.
0 reposts1 like